Wikipedia -WSS

Wikipedia

author：explore 2025-09-28 00:51:38 - browse：4

Sens. Ron Wyden and Mike Crapo introduced a mental health, PBM reform and substance use policy package. Drew Angerer/Getty Images

WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do for medications.

The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) is slated to be marked up on Nov. 8, and includes policy on a broad range of health care priorities, including substance abuse and mental health care, and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

The most impactful proposal would allow the Department of Health and Human Services to designate a list of so-called discounted drugs. Medicare beneficiaries taking those drugs would see their share of the cost based on the net price, rather than the list price, under the new proposal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

explore

WSS

Let's speed up science by embracing open access publishing

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Letters to First Opinion on caregivers, digital health, and more

The Pandemic Treaty must support building strong health systems

Organ aging and disease risk measured by new blood test

How to pay for weight loss drugs and save Medicare

entertainment

Wikipedia

focus

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Medical records are filled with copy

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Dobbs anniversary: the lost opportunity of abortion as health care

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Malaria cases in Florida and Texas: Here’s what you need to know

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Malaria cases in Florida and Texas: Here’s what you need to know

Rep. Raul Ruiz on the physician shortage and more

hotspot

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Mayo Clinic plans $5B tech

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

What to do when lifesaving products contribute to climate change

At ASCO, AstraZeneca reports strong data for breast cancer drug

leisure time

explore

leisure time

Wikipedia